Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dave Hoskins"'
Autor:
Peter Weiss-Penzias, Kenneth Coale, Wesley Heim, Daniel Fernandez, Andrew Oliphant, Celeste Dodge, Dave Hoskins, James Farlin, Robert Moranville, Alex Olson
Publikováno v:
Elementa: Science of the Anthropocene (2016)
Abstract Marine fog water samples were collected over two summers (2014–2015) with active strand collectors (CASCC) at eight coastal sites from Humboldt to Monterey counties in California, USA, and on four ocean cruises along the California coastli
Externí odkaz:
https://doaj.org/article/0a075753b321474493b565d5edfb251c
Impact of an Atrial Fibrillation Decision Support Tool on thromboprophylaxis for atrial fibrillation
Autor:
Matthew L. Flaherty, Ruth E. Wise, Dave Hoskins, Mark H. Eckman, Dawn Kleindorfer, Lora Arduser, Brett M. Kissela, Alexandru Costea, Barbara Speer, Brett M. Harnett, Peter Baker, Carlos Aguilar, John Kues, Dylan L. Steen, Megan Sullivan, Anthony C. Leonard, Nita Walker, Gregory Y.H. Lip, Robert Ireton
Publikováno v:
American Heart Journal. 176:17-27
Background Appropriate thromboprophylaxis for patients with atrial fibrillation (AF) remains a national challenge. Methods We hypothesized that provision of decision support in the form of an Atrial Fibrillation Decision Support Tool (AFDST) would im
Autor:
Nita Walker, Matthew L. Flaherty, Brett M. Kissela, Ruth E. Wise, Megan Sullivan, Peter Baker, Dylan L. Steen, Anthony C. Leonard, John Kues, Dawn Kleindorfer, Dave Hoskins, Robert Ireton, Brett M. Harnett, Alexandru Costea, Barbara Speer, Lora Arduser, Gregory Y.H. Lip, Mark H. Eckman, Carlos Aguilar
Publikováno v:
Journal of the American Geriatrics Society. 64:1054-1060
Objectives To assess the appropriateness of oral anticoagulant therapy (OAT) in women and elderly adults, looking for patterns of undertreatment or unnecessary treatment. Design Retrospective cohort study. Setting Primary care practices of an academi
Autor:
Brett M. Kissela, Anthony C. Leonard, Lora Arduser, Rajan Prakash, Megan Sullivan, Carlos Aguilar, Nita Walker, Matthew L. Flaherty, Ruth E. Wise, Gregory Y.H. Lip, Dawn Kleindorfer, Robert Ireton, Mark H. Eckman, Faisal Khan, Peter Baker, Barbara Speer, Brett M. Harnett, Alexandru Costea, Dave Hoskins, John Kues
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 7:680-686
Background— Guidelines for anticoagulant therapy in patients with atrial fibrillation are based on stroke risk as calculated by either the CHADS 2 or the CHA 2 DS 2 VASc scores and do not integrate bleeding risk in an explicit, quantitative manner.